Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans: Effect of the Time of Administration and Consecutive Day Administration of Commonly Used Dosages

NCT02050932 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.

NCT NCT02050932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02050932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans: Effect of the Time of Administration and Consecutive Day Administration of Commonly Used Dosages
Lead sponsor
Swiss Federal Institute of Technology
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
December 31, 2013
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency